Valuation: Abbott Laboratories

Market Cap 17TCr 15TCr 14TCr 13TCr 24TCr 16,10900Cr 24TCr 1,68100Cr 65TCr 8,20400Cr 63TCr 61TCr 26,35000Cr P/E 2026 *
27.4x
P/E 2027 * 21.2x
Enterprise Value 19TCr 17TCr 16TCr 14TCr 27TCr 18,41400Cr 28TCr 1,92200Cr 74TCr 9,37800Cr 72TCr 70TCr 30,12100Cr EV / Sales 2026 *
3.81x
EV / Sales 2027 * 3.45x
Free-Float
86.16%
Yield 2026 *
2.66%
Yield 2027 * 2.83%
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 17TCr
-2.17%-6.57%-27.81%-0.17% 17TCr
+0.17%-3.20%-9.24%+10.31% 11TCr
-0.88%-0.16%-26.16%-0.11% 11TCr
-0.69%-3.57%-47.61%-12.45% 7.6TCr
+3.17%-0.80%-0.88%+72.13% 5.73TCr
-0.52%-2.44%-4.86%-31.12% 4.88TCr
-2.64%+3.07%+15.89%+57.32% 5.02TCr
-0.85%-0.82%-18.96%+18.41% 4.11TCr
-0.07%-1.71%+28.15%-7.58% 3.26TCr
Average -0.40%-1.46%-10.17%+11.86% 7.7TCr
Weighted average by Cap. -0.57%-2.07%-16.61%+8.88%

Financials

2026 *2027 *
Net sales 5.02TCr 4.46TCr 4.17TCr 3.8TCr 7.15TCr 4,83400Cr 7.25TCr 50TCr 20TCr 2,46200Cr 19TCr 18TCr 7,90700Cr 5.45TCr 4.84TCr 4.53TCr 4.13TCr 7.77TCr 5,25000Cr 7.88TCr 55TCr 21TCr 2,67400Cr 20TCr 20TCr 8,58800Cr
Net income 630.32Cr 559.85Cr 523.55Cr 477.1Cr 898.21Cr 61TCr 910.55Cr 6.33TCr 2.45TCr 31TCr 2.37TCr 2.32TCr 99TCr 797.76Cr 708.57Cr 662.63Cr 603.84Cr 1.14TCr 77TCr 1.15TCr 8.02TCr 3.1TCr 39TCr 3TCr 2.93TCr 1,25600Cr
Net Debt 2.39TCr 2.13TCr 1.99TCr 1.81TCr 3.41TCr 2,30500Cr 3.46TCr 24TCr 9.31TCr 1,17400Cr 8.99TCr 8.79TCr 3,77000Cr 2.1TCr 1.86TCr 1.74TCr 1.59TCr 2.99TCr 2,01800Cr 3.03TCr 21TCr 8.15TCr 1,02800Cr 7.87TCr 7.7TCr 3,30100Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB